Eugènia Negredo

Universitat de Vic - Universitat Central de Catalunya — Spain

Medicine · Health Sciences

49h-index8.3kcitations269works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(152), HIV Research and Treatment(140), HIV-related health complications and treatments(124), HIV/AIDS Research and Interventions(95), Pneumocystis jirovecii pneumonia detection and treatment(17)

Publications260 total

Transforming long-term care for people with HIV: Movimiento AHORA
Enfermedades infecciosas y microbiologia clinica (English ed )·2025
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis
HIV Medicine·2025
Muscular and plasma markers for early identification of frailty and sarcopenia states in people with HIV
AIDS·2025
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program
Open Forum Infectious Diseases·2025· 1 citedOpen Access
Barriers and Facilitators of Implementation of the Non-Hospital-Based Administration of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV: Qualitative Data from the HOLA Study
Viruses·2025Open Access
Short Assessment for People with Human Immunodeficiency Virus (HIV) Aged 50 Years or Older: Essential Tests from Comprehensive Geriatric Assessment
Viruses·2025· 1 citedOpen Access
Transforming long-term care for people with HIV: Movimiento AHORA
Enfermedades Infecciosas y Microbiología Clínica·2025
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial
Journal of Antimicrobial Chemotherapy·2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease
The Lancet HIV·2025· 9 citedOpen Access
Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol
BMJ Open·2025· 2 citedOpen Access
Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in Antiretroviral-therapy-naive Adults With HIV: A Multicenter Prospective Cohort Study
Clinical Infectious Diseases·2025· 9 citedOpen Access
Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population
International Journal of Molecular Sciences·2024· 2 citedOpen Access
Epidemiological, clinical and mortality trends in people living with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands
AIDS·2024· 1 cited
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV
AIDS·2024· 5 citedOpen Access
Low Levels of Cortisol are Associated with HIV Infection in Older People: A Hormonal Substudy in the OVER50 Cohort
Current HIV Research·2024
Functional and structural neuroretinal disorders in HIV Controllers. Prospective cohort study
HIV Medicine·2024Open Access
Early virological failure with cabotegravir/rilpivirine
Journal of Antimicrobial Chemotherapy·2024· 5 cited
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials
The Lancet HIV·2023· 25 citedOpen Access
Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV
Frontiers in Immunology·2023· 16 citedOpen Access
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir
Journal of Antimicrobial Chemotherapy·2023· 2 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Bonaventura Clotet(39), Roger Paredes(14), Jordi Puig(14), Carmina R. Fumaz(11), Guillem Sirera(10), Anna Bonjoch(10), Núria Pérez‐Álvarez(9), José Moltó(9), Julià Blanco(8), Joan Romeu(7), Peré Domingo(7), Christoph Stephan(7), Carla Estany(6), Sílvia Gel(6), José A. Muñoz-Moreno(6), José Ramón Arribas(6), Jean‐Michel Molina(6), Cristina Tural(5), David M. Burger(5), Lı́dia Ruiz(5)